Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...

The retro, rugged Travoca Rigel is a portable mini fridge with dual-zone compartments and individual digital temperature control, featuring a detachable lid. There are three ways to power the Rigel: ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Veppanu leverages PROTAC-mediated ubiquitin–proteasome degradation to eliminate mutant estrogen receptor, aiming to bypass ESR1-driven endocrine resistance rather than merely inhibiting receptor ...

May 12 (Reuters) - Rigel Pharmaceuticals (RIGL.O), opens new tab said on Tuesday it has struck a global licensing deal for Arvinas (ARVN.O), opens new tab and Pfizer's (PFE.N), opens new tab recently ...

Pfizer and Arvinas have landed a buyer for the newly approved breast cancer med Veppanu, selling an exclusive global license to Rigel Pharmaceuticals for $85 million upfront and potentially hundreds ...

Just a few months after ripping up the central nervous system-focused portion of its RIPK1 deal with Rigel Pharmaceuticals, Eli Lilly has now thrown out the rest of the pact too. Lilly notified Rigel ...

Shares of Rigel Pharmaceuticals (RIGL) reached a four-month low on Wednesday after the company, with its Q4 2025 results, projected a revenue decline for 2026 driven by a sharp fall in its contract ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

It has been seven years since my first Rigel Pharmaceuticals (RIGL) article, where I was bullish on TAVALISSE and the company's impressive pipeline. I was eyeing a potential buy early in 2019 as the ...